← brief for 2026-10-25 · Transplant & xeno

Sodium-Glucose Cotransporter-2 Inhibitor Use in Kidney Transplant Recipients With Post-Transplantation Diabetes Mellitus - A Cross-Sectional Study.

Article C Peer reviewed Observational

Key takeaways

This study looked at kidney transplant patients in Norway who developed diabetes after their surgery. It checked if a common diabetes drug called an SGLT2 inhibitor helped their bodies process sugar better. The results show a link between using this drug and a healthier metabolic profile. However, this type of study cannot prove that the drug caused the improvement.

Who did this work

Hoven A · Tøftum ST · Hovd M · Åsberg A · Kongerud IC · Jenssen TG · Nordheim E

Source

Article · PubMed, the drug frontier · 2026 Oct 24
https://pubmed.ncbi.nlm.nih.gov/42926181/